Login / Signup
Alazne Dominguez-Monedero
ORCID
Publication Activity (10 Years)
Years Active: 2018-2018
Publications (10 Years): 1
Top Topics
Type Iii
Positive Breast Cancer
Genome Editing
Adverse Drug
Top Venues
ACS synthetic biology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Alazne Dominguez-Monedero
,
Jamie A Davies
Tamoxifen- and Mifepristone-Inducible Versions of CRISPR Effectors, Cas9 and Cpf1.
ACS synthetic biology
7 (9) (2018)